Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Response Biomedical Corp

Response Biomedical is commercializing a new class of diagnostic with the world's only immunoassay platform that provides lab quality information in a matter of minutes, anywhere, every time. RAMP® tests are commercially available for three cardiac markers used in the early detection of heart attack, environmental detection of West Nile virus, and biodefense applications including the detection of anthrax, ricin, smallpox, and botulinum toxin.For clinical applications, RAMP is to be used by healthcare professionals at the point-of-care, including physicians' offices, medical clinics, hospital emergency departments and laboratories worldwide. The Company has received regulatory clearance from Health Canada and the US Food and Drug Administration to market its RAMP Cardiac Marker Tests for detecting myoglobin, troponin I and CK-MB to assist in the rapid diagnosis of heart attack or acute myocardial infarction. Rapid diagnosis of heart attacks is critical to patient outcomes. Cardiac markers are proteins released in the blood following a heart attack. RAMP provides a quantitative result in approximately 15 minutes, compared to several hours turnaround time for traditional laboratory testing. The results from independent multi-center US clinical trials of RAMP tests for troponin I and CK-MB demonstrated improved performance over the current market leading quantitative point-of-care system.
The Company is expanding its international marketing and distribution network, as it pursues further clinical applications in stroke, oncology and infectious disease testing. The Company has achieved CE Mark and its Quality Management System is registered to ISO 9000: 2000 and ISO 13485:1996.


Contact Details:
100-8900 Glenlyon Parkway
Burnaby
British Columbia
V5J 5J8
Canada
Tel:
Fax:604.456.6066
Email:info@responsebio.com
WWW:

www.responsebio.com/




Loading...

Recent Publications by Response Biomedical Corp:

RAMP anthrax test cartridge.
A study has been made of the application of radio frequency (RF)...
29th July, 2005
Response Biomedical Corp., 8081 Lougheed Hwy, Burnaby, British Columbia J AOAC Int. 2005 Jan-Feb;88(1):202-3.

Press Releases on Response Biomedical Corp:

BioPortfolio Logo
Reportlinker Adds Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads 5th November, 2009 Reportlinker
NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 10th June, 2009 Response Biomedical Corp.
VANCOUVER, June 10 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) is pleased to announce that Livleen Kaler has been appointed Vice President Finance &
Response Biomedical Closes $12.65 million Unit Offering 21st May, 2009 Response Biomedical Corp.
VANCOUVER, May 21 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) (the "Company") announced today that it has closed its previously announced public
Response Biomedical Announces Terms of Unit Offering 7th May, 2009 Response Biomedical Corp.
VANCOUVER, May 7 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) (the "Company") announced today that it has entered into an underwriting agreement with an
Response Biomedical Announces Proposed Unit Offering 5th May, 2009 Response Biomedical Corp.
VANCOUVER, May 5 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) (the "Company") today announced that it has filed a preliminary short form prospectus in

BioNews Results for Response Biomedical Corp:

StockProfiler.US: Stock Watch: RPBIF, KCMH, BEAC
Individual.com:  Nov 4 2009 1:03AM Matching: response biomedical corp

Response Biomedical Corp Patents:

US Patent No.Title
7056473 Method and apparatus of quantitative assays
6509196 Compensation for non-specific signals in quantitative immunoassays

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 275 times since April 2007, the link to the organisation's website has been followed 47 times

Search for more companies in Burnaby

Search for more companies in British Columbia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Response Biomedical Corp

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.